Promising Outlook for MoonLake’s Sonelokimab in Psoriatic Arthritis Treatment
MoonLake Immunotherapeutics (MLTX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday.
Too Old to Operate11h
Impact of Depression and Anxiety on Remission in Arthritis
The following is a summary of “Association between depression and anxiety and inability to achieve remission in rheumatoid ...
Hosted on MSN3d
Diseases That Mimic Rheumatoid Arthritis
Sicca is not a feature of RA. Psoriatic arthritis (PSA) is a type of arthritis linked to the autoimmune skin condition ...
rheumatologyadvisor3d
Secukinumab vs Adalimumab More Effective for Skin Symptoms in PsA
Similar percentages of patients with PsA receiving secukinumab vs adalimumab achieved an ACR20 response at 12 weeks.
Enlivex Announces the Dosing of the First Patient in a Phase I Clinical Trial Evaluating Allocetra in Patients with Psoriatic Arthritis
Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced the completion of the dosing and initial follow-up period for ...
Business Wire1d
Global Healthy Living Foundation Brings Innovative and Patient-Centered Polymyalgia Rheumatica, Psoriatic, and Rheumatoid Arthritis Research to ACR Conv…
Global Healthy Living Foundation has 12 posters and Polymyalygia Rheumataca, Psoriasis and RA Research at American College of ...
Too Old to Operate11d
Prospective Analysis of PsA Incidence in Patients with PsO
The following is a summary of “Incidence of Psoriatic Arthritis in a Primary Care Psoriasis Population in the United Kingdom” published in the November 2024 issue of Rheumatology by Rudge et al.
Yahoo Finance8d
Johnson & Johnson advances leadership in rheumatic disease innovation with 43 abstracts at ACR 2024
New data for investigational nipocalimab in Sjögren's Disease (SjD) and new research on the impact of TREMFYA ® (guselkumab) in psoriatic arthritis (PsA) will be highlighted across three oral ...